Anil Kapur - 06 Jun 2024 Form 4 Insider Report for GERON CORP (GERN)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GERN	Employee Stock Option (right to buy)	Award	$0	+250,000		$0.000000	250,000	06 Jun 2024	Common Stock	250,000	$1.43	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Performance-based stock option granted on December 2, 2019 and vested in full on June 6, 2024 upon approval of the NDA by the US FDA for imetelstat in lower risk MDS.